Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kay L. Medina is active.

Publication


Featured researches published by Kay L. Medina.


Nature Immunology | 2001

Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen

Kay L. Medina; Karla P. Garrett; Linda F. Thompson; Maria Isabel D. Rossi; Kimberly J. Payne; Paul W. Kincade

Estrogen is a negative regulator of lymphopoiesis and provides an experimental tool for probing relationships between lymphocyte precursors and stem cells. We found that expression of lymphocyte-associated genes and immunoglobulin (Ig) gene rearrangement occurred before CD45R acquisition. Lymphoid-restricted progenitors that were Lin−IL-7Rα+c-kitloTdT+ (lineage marker−, interleukin receptor 7α+, c-kitlo and terminal deoxynucleotidyl transferase+) were selectively depleted in estrogen-treated mice; within a less differentiated Lin−c-kithi fraction, functional precursors of B and T, but not myeloid, cells were also selectively depleted. TdT and an Ig heavy chain transgene were detected within a hormone-regulated Lin−c-kithiSca-1+CD27+Flk-2+IL-7Rα− subset of this multipotential progenitor population. Identification of these extremely early lymphoid precursors should facilitate investigation of the molecular mechanisms that control lineage-fate decisions in hematopoiesis.


Nature Immunology | 2004

Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription.

Holly Maier; Rachel Ostraat; Hua Gao; Scott Fields; Susan A. Shinton; Kay L. Medina; Tomokatsu Ikawa; Cornelis Murre; Harinder Singh; Richard R. Hardy; James Hagman

Cd79a (called mb-1 here) encodes the Ig-α signaling component of the B cell receptor. The early B cell–specific mb-1 promoter was hypermethylated at CpG dinucleotides in hematopoietic stem cells but became progressively unmethylated as B cell development proceeded. The transcription factor Pax5 activated endogenous mb-1 transcription in a plasmacytoma cell line, but could not when the promoter was methylated. In this context, early B cell factor (EBF), a transcription factor required for B lymphopoiesis, potentiated activation of mb-1 by Pax5. EBF and the basic helix-loop-helix transcription factor E47 each contributed to epigenetic modifications of the mb-1 promoter, including CpG demethylation and nucleosomal remodeling. EBF function was enhanced by interaction with the transcription factor Runx1. These data suggest a molecular basis for the hierarchical dependence of Pax5 function on EBF and E2A in B lymphocyte development.


Nature Immunology | 2005

Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5.

Eric Bertolino; Kay L. Medina; Evan Parganas; James N. Ihle; Harinder Singh

Rearrangement of immunoglobulin heavy-chain variable (VH) gene segments has been suggested to be regulated by interleukin 7 signaling in pro–B cells. However, the genetic evidence for this recombination pathway has been challenged. Furthermore, no molecular components that directly control VH gene rearrangement have been elucidated. Using mice deficient in the interleukin 7–activated transcription factor STAT5, we demonstrate here that STAT5 regulated germline transcription, histone acetylation and DNA recombination of distal VH gene segments. STAT5 associated with VH gene segments in vivo and was recruited as a coactivator with the transcription factor Oct-1. STAT5 did not affect the nuclear repositioning or compaction of the immunoglobulin heavy-chain locus. Therefore, STAT5 functions at a distinct step in regulating distal VH recombination in relation to the transcription factor Pax5 and histone methyltransferase Ezh2.


Journal of Clinical Investigation | 2002

Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins

Takafumi Yokota; C. S. Reddy Meka; Kay L. Medina; Hideya Igarashi; Masahiko Takahashi; Makoto Nishida; Kenji Oritani; Jun-ichiro Miyagawa; Tohru Funahashi; Yoshiaki Tomiyama; Yuji Matsuzawa; Paul W. Kincade

Adiponectin, an adipocyte-derived hormone, was recently shown to have potential therapeutic applications in diabetes and obesity because of its influence on glucose and lipid metabolism. We found that brown fat in normal human bone marrow contains this protein and used marrow-derived preadipocyte lines and long-term cultures to explore potential roles in hematopoiesis. Recombinant adiponectin blocked fat cell formation in long-term bone marrow cultures and inhibited the differentiation of cloned stromal preadipocytes. Adiponectin also caused elevated expression of cyclooxygenase-2 (COX-2) by these stromal cells and induced release of prostaglandin E(2) (PGE(2)). The COX-2 inhibitor Dup-697 prevented the inhibitory action of adiponectin on preadipocyte differentiation, suggesting involvement of stromal cell-derived prostanoids. Furthermore, adiponectin failed to block fat cell generation when bone marrow cells were derived from B6,129S(Ptgs2tm1Jed) (COX-2(+/-)) mice. These observations show that preadipocytes represent direct targets for adiponectin action, establishing a paracrine negative feedback loop for fat regulation. They also link adiponectin to the COX-2-dependent PGs that are critical in this process.


Nature Medicine | 2000

Limitin : An interferon-like cytokine that preferentially influences B-lymphocyte precursors

Kenji Oritani; Kay L. Medina; Yoshiaki Tomiyama; Jun Ishikawa; Yu Okajima; Megumu Ogawa; Takahumi Yokota; Keisuke Aoyama; Isao Takahashi; Paul W. Kincade; Yuji Matsuzawa

We have identified an interferon-like cytokine, limitin, on the basis of its ability to arrest the growth of or kill lympho–hematopoietic cells. Limitin strongly inhibited B lymphopoiesis in vitro and in vivo but had little influence on either myelopoiesis or erythropoiesis. Because limitin uses the interferon α/β receptors and induces interferon regulatory factor-1, it may represent a previously unknown type I interferon prototype. However, preferential B-lineage growth inhibition and activation of Janus kinase 2 in a myelomonocytic leukemia line have not been described for previously known interferons.


Journal of Immunology | 2003

Adiponectin, a Fat Cell Product, Influences the Earliest Lymphocyte Precursors in Bone Marrow Cultures by Activation of the Cyclooxygenase-Prostaglandin Pathway in Stromal Cells

Takafumi Yokota; C. S. Reddy Meka; Taku Kouro; Kay L. Medina; Hideya Igarashi; Masahiko Takahashi; Kenji Oritani; Tohru Funahashi; Yoshiaki Tomiyama; Yuji Matsuzawa; Paul W. Kincade

Adiponectin, an adipocyte-derived hormone, is attracting considerable interest as a potential drug for diabetes and obesity. Originally cloned from human s.c. fat, the protein is also found in bone marrow fat cells and has an inhibitory effect on adipocyte differentiation. The aim of the present study is to explore possible influences on lymphohematopoiesis. Recombinant adiponectin strongly inhibited B lymphopoiesis in long-term bone marrow cultures, but only when stromal cells were present and only when cultures were initiated with the earliest category of lymphocyte precursors. Cyclooxygenase inhibitors abrogated the response of early lymphoid progenitors to adiponectin in stromal cell-containing cultures. Furthermore, PGE2, a major product of cyclooxygenase-2 activity, had a direct inhibitory influence on purified hematopoietic cells, suggesting a possible mechanism of adiponectin action in culture. In contrast to lymphopoiesis, myelopoiesis was slightly enhanced in adiponectin-treated bone marrow cultures, and even when cultures were initiated with single lymphomyeloid progenitors. Finally, human B lymphopoiesis was also sensitive to adiponectin in stromal cell cocultures. These results suggest that adiponectin can negatively and selectively influence lymphopoiesis through induction of PG synthesis. They also indicate ways that adipocytes in bone marrow can contribute to regulation of blood cell formation.


Immunological Reviews | 1994

Sex Hormones as Negative Regulators of Lymphopoiesis

Paul W. Kincade; Kay L. Medina; G. Smithson

B lymphocytes, together with cells of seven other lineages, are made in large numbers from precursors in the bone marrow. Using cell culture models and recombinant proteins, progress has been rapid in identifying cytokines which could potentially regulate the proliferation, differentiation and migration of B-cell precursors. However, we still know little about molecular mechanisms which are important for maintaining steady-state conditions in vivo. B lymphopoiesis is severely diminished during pregnancy in normal mice and this provided a clue that sex hormones might be important negative regulators. Administration of estrogens alone, or in combination with progesterone, preferentially suppressed IL-7 responding cells and their progeny in bone marrow. There is precedent for these observations in the thymus, which transiently involutes during pregnancy, and also atrophies following estrogen treatment. The actual mechanism(s) through which sex steroids influence lymphopoiesis remain unclear, but cell culture experiments should be informative about potential interactions between hormones, the bone marrow microenvironment, and lymphocyte precursors. These findings raise a number of other important issues. For example, we need to learn if sex steroids are produced and/or concentrated locally within the marrow, if human lymphopoiesis is sensitive to these hormones, and if production of lymphocytes can be augmented in aging and in immunodeficiency by hormone manipulation.


Immunological Reviews | 2000

Early B‐lymphocyte precursors and their regulation by sex steroids

Paul W. Kincade; Kay L. Medina; Kimberly J. Payne; Maria Isabel D. Rossi; Kim Sue R S Tudor; Yoshio Yamashita; Taku Kouro

Summary: This review describes an improved characterization of early B‐lymphocyte precursors in mice and the remarkable sensitivity of the same cells to hormones. The nuclear enzyme terminal deoxynucleotidyl transferase (TdT) was used as a marker to image and characterize bone marrow cells lacking all lineage‐associated markers. Most early TdT+ precursors have a distinctive density of c‐kit and express the interleukin‐7Ra chain, as well as flt‐3/flk2, but lack CD34. An understanding of those cell surface properties made it possible to obtain highly enriched, viable cells with the potential to give rise to CD19+ lymphocytes in culture. A series of other flow cytometry and culture experiments suggested a possible differentiation sequence for these early pro‐B cells. This new model was used to advantage in our studies of sex steroids. It appears that early precursors represent a hormone‐sensitive control point for determining numbers of new B lymphocytes that are produced within bone marrow. We also compare and contrast these findings with B lymphopoiesis in humans.


Current Opinion in Hematology | 2005

Genetic networks that regulate B lymphopoiesis

Kay L. Medina; Harinder Singh

Purpose of reviewThe B cell developmental pathway represents a leading model within the hematopoietic system for the analysis of genetic networks, which orchestrate cell fate specification and commitment. Considerable progress is being achieved in the characterization of regulatory components that comprise such networks and examining their connectivity. These components include the cytokine receptors Flk2 and IL-7R as well as the transcription factors PU.1, Ikaros, Bcl11a, E2A, EBF, and Pax-5. Based on new experimental evidence, a comprehensive model is proposed that invokes sequentially acting and inter-dependent regulatory modules that instruct the generation of B cell precursors from multipotential hematopoietic progenitors. Recent findingsThe transcription factor PU.1 regulates the generation of lymphoid progenitors that express Flk2 and IL-7R. IL-7R receptor signaling appears to function in specification of the B cell fate. The transcription factor EBF can bypass the requirement for PU.1 and E2A in early B cell development. Pax-5 expression and function are contingent on EBF. SummaryAssembly of gene regulatory networks involved in cell fate specification may facilitate the efficient and directed generation of lineage-specific hematopoietic progenitors from embryonic stem cells for therapeutic purposes.


Journal of Immunology | 2001

Relatively Normal Human Lymphopoiesis but Rapid Turnover of Newly Formed B Cells in Transplanted Nonobese Diabetic/SCID Mice

Maria Isabel D. Rossi; Kay L. Medina; Karla P. Garrett; G. R. Kolar; L. D. Shultz; J. D. Capra; Patrick C. Wilson; A. Schipul; Paul W. Kincade

Human B lineage lymphocyte precursors in chimeric nonobese diabetic/SCID mice transplanted with umbilical cord blood cells were directly compared with those present in normal bone marrow. All precursor subsets were represented and in nearly normal proportions. Cell cycle activity and population dynamics were investigated by staining for the Ki-67 nuclear Ag as well as by incorporation experiments using 5-bromo-2′-deoxyuridine. Again, this revealed that human B lymphopoiesis in chimeras parallels that in normal marrow with respect to replication and progression through the lineage. Moreover, sequencing of Ig gene rearrangement products showed that a diverse repertoire of VH genes was utilized by the newly formed lymphocytes but there was no evidence for somatic hypermutation. The newly formed B cells frequently acquired the CD5 Ag and had a short life span in the periphery. Thus, all molecular requirements for normal B lymphocyte formation are present in nonobese diabetic/SCID mice, but additional factors are needed for recruitment of B cells into a fully mature, long-lived pool. The model can now be exploited to learn about species restricted and conserved environmental cues for human B lymphocyte production.

Collaboration


Dive into the Kay L. Medina's collaboration.

Top Co-Authors

Avatar

Paul W. Kincade

Oklahoma Medical Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Harinder Singh

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kimberly J. Payne

Oklahoma Medical Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Maria Isabel D. Rossi

Oklahoma Medical Research Foundation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Karla P. Garrett

Oklahoma Medical Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Glennda Smithson

Oklahoma Medical Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Jagan M. R. Pongubala

Howard Hughes Medical Institute

View shared research outputs
Top Co-Authors

Avatar

Jeffrey M. Gimble

Oklahoma Medical Research Foundation

View shared research outputs
Researchain Logo
Decentralizing Knowledge